UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism

The European respiratory journal, 2010-04, Vol.35 (4), p.735-741

2010

Volltextzugriff (PDF)

Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man

International journal of clinical practice (Esher), 2010-11, Vol.64 (s168), p.5-13

2010

Volltextzugriff (PDF)

Right heart function and haemodynamics in pulmonary hypertension

International journal of clinical practice (Esher), 2008-07, Vol.62 (s160), p.11-19

2008

Volltextzugriff (PDF)

Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography

International journal of clinical practice (Esher), 2009-09, Vol.63 (s162), p.4-19

2009

Volltextzugriff (PDF)

P3671Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Clinical And Hemodynamic Characterization Of Intermediate- And Long-Term Responders To Iv Prostacyclin

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C69 CONTROVERSY: ASSESSING AND TREATING THE FAILING RIGHT VENTRICLE: Proteins Involved In Dysfunctional Rv Hypertrophy In Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C71 CRYSTAL BALL: CLINICAL FEATURES OF PULMONARY VASCULAR DISEASE II: Biomarker-Specific Differences Between Transpulmonary And Peripheral Arterial-Venous Blood Sampling

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

D53 THE PROMISED LAND: CLINICAL STUDIES IN PULMONARY HYPERTENSION: End Tidal Co2 As A Predictor Of Outcomes In Patients With Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

B96 HUNGRY HEART: RV FUNCTION IN PH: Altered Insulin Signaling In Mutant Bmpr2 Cardiomyocytes Associated With Mitochondrial Dysfunction

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

A28 FROM PE TO CTEPH: FADE AWAY OR NOT?: Blood Transcriptome In Patients With Chronic Thromboembolic Pulmonary Hypertension Differs From Patients With Pulmonary Arterial Hypertension And Healthy Controls

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

C27 LET'S PRETEND WE'RE MARRIED: THE RIGHT VENTRICLE AND THE PULMONARY VASCULATURE: Tp Receptor Antagonism Improves Right Ventricular Adaptation To Pressure Overload Via Changes In Calcium Signaling

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C59 BIOMARKERS AND PROGNOSTIC FACTORS IN PULMONARY HYPERTENSION: Plasma Adiponectin In Idiopathic And Heritable Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C60 CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: Clinical Predictors Of Improvement After Pulmonary Thromboendarterectomy In Patients With Chronic Thromboembolic Pulmonary Hypertension

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

A51 EXPERIMENTAL MODELS OF PULMONARY HYPERTENSION: Experimental Insulin Resistance Promotes Lung Reactive Oxygen Species Generation And Pulmonary Hypertension In Mice

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C61 RIGHT VENTRICLE: STRUCTURE AND FUNCTION: Thromboxane/prostanoid Receptor Antagonism Alters Immune And Signaling Response To Right Ventricular Pressure Overload

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C28 SEX, DRUGS, AND PULMONARY HYPERTENSION: The Aromatase Inhibitor Anastrozole Reverses Established Pah In Bmpr2 Mutant Mice

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Cardiac Gene Polymorphisms Are Associated With Favorable Prostacyclin Response In Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

C106 WRECKING BALL: NEW PARADIGMS IN UNDERSTANDING AND TREATMENT OF PH: Subclinical Albuminuria As A Prognostic Indicator In Group 1 Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Uptravi® (selexipag): The Users Drug Registry (sphere): A Us-Based, Prospective Drug Registry Of Selexipag In Clinical Practice

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

D19 CLINICAL STUDIES IN PH: Comprehensive Characterization Of Insulin Resistance And Its Association With Ventricular Function In Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

C54 TREATMENT OF PULMONARY HYPERTENSION: Causes Of Death In Pulmonary Arterial Hypertension Patients Not Treated With Parenteral Prostaglandins At A Referral Center

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

D25 ETIOLOGY AND DETERMINANTS OF PROGNOSIS IN PULMONARY HYPERTENSION: Determining The Clinical And Hemodynamic Profile Of Combined Pulmonary Hypertension In A Large De-Identified Database

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C106 WRECKING BALL: NEW PARADIGMS IN UNDERSTANDING AND TREATMENT OF PH: Evidence Of Shared Genetic Architecture Between Combined Pulmonary Hypertension And Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

A106 MOLECULAR MECHANISMS OF RIGHT VENTRICULAR DYSFUNCTION: Right Ventricular Adaptation To Load Stress Is Improved By Thromboxane Receptor Antagonism

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Englisch
(306)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(183)
Life Sciences & Biomedicine
(180)
Humans
(121)
Respiratory System
(109)
Pulmonary Hypertension
(105)
Cardiovascular System & Cardiology
(84)
Cardiac & Cardiovascular Systems
(83)
Female
(60)
Male
(57)
General & Internal Medicine
(56)
Pulmonary Arterial Hypertension
(50)
Middle Aged
(46)
Hemodynamics
(39)
Adult
(37)
Hypertension, Pulmonary - Physiopathology
(36)
Critical Care Medicine
(35)
Pulmonary Arteries
(35)
Hypertension
(32)
Original Research
(25)
Animals
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism

Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man

Right heart function and haemodynamics in pulmonary hypertension

Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography

P3671Selexipag dosing and titration in the first 500 patients enrolled in SPHERE (SelexiPag: tHe UsErs dRug rEgistry)

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Clinical And Hemodynamic Characterization Of Intermediate- And Long-Term Responders To Iv Prostacyclin

C69 CONTROVERSY: ASSESSING AND TREATING THE FAILING RIGHT VENTRICLE: Proteins Involved In Dysfunctional Rv Hypertrophy In Pulmonary Arterial Hypertension

C71 CRYSTAL BALL: CLINICAL FEATURES OF PULMONARY VASCULAR DISEASE II: Biomarker-Specific Differences Between Transpulmonary And Peripheral Arterial-Venous Blood Sampling

D53 THE PROMISED LAND: CLINICAL STUDIES IN PULMONARY HYPERTENSION: End Tidal Co2 As A Predictor Of Outcomes In Patients With Pulmonary Arterial Hypertension

B96 HUNGRY HEART: RV FUNCTION IN PH: Altered Insulin Signaling In Mutant Bmpr2 Cardiomyocytes Associated With Mitochondrial Dysfunction

A28 FROM PE TO CTEPH: FADE AWAY OR NOT?: Blood Transcriptome In Patients With Chronic Thromboembolic Pulmonary Hypertension Differs From Patients With Pulmonary Arterial Hypertension And Healthy Controls

C27 LET'S PRETEND WE'RE MARRIED: THE RIGHT VENTRICLE AND THE PULMONARY VASCULATURE: Tp Receptor Antagonism Improves Right Ventricular Adaptation To Pressure Overload Via Changes In Calcium Signaling

C59 BIOMARKERS AND PROGNOSTIC FACTORS IN PULMONARY HYPERTENSION: Plasma Adiponectin In Idiopathic And Heritable Pulmonary Arterial Hypertension

C60 CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: Clinical Predictors Of Improvement After Pulmonary Thromboendarterectomy In Patients With Chronic Thromboembolic Pulmonary Hypertension

A51 EXPERIMENTAL MODELS OF PULMONARY HYPERTENSION: Experimental Insulin Resistance Promotes Lung Reactive Oxygen Species Generation And Pulmonary Hypertension In Mice

C61 RIGHT VENTRICLE: STRUCTURE AND FUNCTION: Thromboxane/prostanoid Receptor Antagonism Alters Immune And Signaling Response To Right Ventricular Pressure Overload

C28 SEX, DRUGS, AND PULMONARY HYPERTENSION: The Aromatase Inhibitor Anastrozole Reverses Established Pah In Bmpr2 Mutant Mice

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Cardiac Gene Polymorphisms Are Associated With Favorable Prostacyclin Response In Pulmonary Arterial Hypertension

C106 WRECKING BALL: NEW PARADIGMS IN UNDERSTANDING AND TREATMENT OF PH: Subclinical Albuminuria As A Prognostic Indicator In Group 1 Pulmonary Arterial Hypertension

A68 WOW: PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION: Uptravi® (selexipag): The Users Drug Registry (sphere): A Us-Based, Prospective Drug Registry Of Selexipag In Clinical Practice

D19 CLINICAL STUDIES IN PH: Comprehensive Characterization Of Insulin Resistance And Its Association With Ventricular Function In Pulmonary Arterial Hypertension

C54 TREATMENT OF PULMONARY HYPERTENSION: Causes Of Death In Pulmonary Arterial Hypertension Patients Not Treated With Parenteral Prostaglandins At A Referral Center

D25 ETIOLOGY AND DETERMINANTS OF PROGNOSIS IN PULMONARY HYPERTENSION: Determining The Clinical And Hemodynamic Profile Of Combined Pulmonary Hypertension In A Large De-Identified Database

C106 WRECKING BALL: NEW PARADIGMS IN UNDERSTANDING AND TREATMENT OF PH: Evidence Of Shared Genetic Architecture Between Combined Pulmonary Hypertension And Pulmonary Arterial Hypertension

A106 MOLECULAR MECHANISMS OF RIGHT VENTRICULAR DYSFUNCTION: Right Ventricular Adaptation To Load Stress Is Improved By Thromboxane Receptor Antagonism

Suchergebnisse filtern